Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Valeria Leuci

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
Current Gene Therapy|December 25, 2013
Genetically redirected T lymphocytes for adoptive immunotherapy of solid tumorsValeria Leuci, Giulia Mesiano, Loretta Gammaitoni, et al.
Expert Opinion on Biological Therapy|March 8, 2011
Gene-modified T lymphocytes in the setting of hematopoietic cell transplantation: potential benefits and possible risksDario Sangiolo, Valeria Leuci, Susanna Gallo, et al.
Cells|April 3, 2021
Cellular Immunotherapy Targeting Cancer Stem Cells: Preclinical Evidence and Clinical PerspectiveChiara Donini, Ramona Rotolo, Alessia Proment, et al.
Expert Opinion on Biological Therapy|May 20, 2014
Immunotherapy of cancer stem cells in solid tumors: initial findings and future prospectiveLoretta Gammaitoni, Valeria Leuci, Giulia Mesiano, et al.
Anti-Cancer Agents in Medicinal Chemistry|November 19, 2013
Ex vivo-activated MHC-unrestricted immune effectors for cancer adoptive immunotherapyValeria Leuci, Giulia Mesiano, Loretta Gammaitoni, et al.
International Journal of Molecular Sciences|June 20, 2019
CAR-Based Strategies beyond T Lymphocytes: Integrative Opportunities for Cancer Adoptive ImmunotherapyRamona Rotolo, Valeria Leuci, Chiara Donini, et al.
Expert Opinion on Biological Therapy|April 17, 2012
Cytokine-induced killer (CIK) cells as feasible and effective adoptive immunotherapy for the treatment of solid tumorsGiulia Mesiano, Maja Todorovic, Loretta Gammaitoni, et al.
Stem Cells (Dayton, Ohio)|September 29, 2009
Efficient transcriptional targeting of human hematopoietic stem cells and blood cell lineages by lentiviral vectors containing the regulatory element of the Wiskott-Aldrich syndrome geneValeria Leuci, Loretta Gammaitoni, Sonia Capellero, et al.
Expert Opinion on Biological Therapy|December 18, 2014
Adoptive immunotherapy against sarcomasGiulia Mesiano, Valeria Leuci, Lidia Giraudo, et al.
Cells|November 27, 2021
EphA2 Expression in Bone Sarcomas: Bioinformatic Analyses and Preclinical Characterization in Patient-Derived Models of Osteosarcoma, Ewing's Sarcoma and ChondrosarcomaGiorgia Giordano, Alessandra Merlini, Giulio Ferrero, et al.
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
Current Gene Therapy|December 25, 2013
Genetically redirected T lymphocytes for adoptive immunotherapy of solid tumorsValeria Leuci, Giulia Mesiano, Loretta Gammaitoni, et al.
Expert Opinion on Biological Therapy|March 8, 2011
Gene-modified T lymphocytes in the setting of hematopoietic cell transplantation: potential benefits and possible risksDario Sangiolo, Valeria Leuci, Susanna Gallo, et al.
Cells|April 3, 2021
Cellular Immunotherapy Targeting Cancer Stem Cells: Preclinical Evidence and Clinical PerspectiveChiara Donini, Ramona Rotolo, Alessia Proment, et al.
Expert Opinion on Biological Therapy|May 20, 2014
Immunotherapy of cancer stem cells in solid tumors: initial findings and future prospectiveLoretta Gammaitoni, Valeria Leuci, Giulia Mesiano, et al.
Anti-Cancer Agents in Medicinal Chemistry|November 19, 2013
Ex vivo-activated MHC-unrestricted immune effectors for cancer adoptive immunotherapyValeria Leuci, Giulia Mesiano, Loretta Gammaitoni, et al.
International Journal of Molecular Sciences|June 20, 2019
CAR-Based Strategies beyond T Lymphocytes: Integrative Opportunities for Cancer Adoptive ImmunotherapyRamona Rotolo, Valeria Leuci, Chiara Donini, et al.
Expert Opinion on Biological Therapy|April 17, 2012
Cytokine-induced killer (CIK) cells as feasible and effective adoptive immunotherapy for the treatment of solid tumorsGiulia Mesiano, Maja Todorovic, Loretta Gammaitoni, et al.
Stem Cells (Dayton, Ohio)|September 29, 2009
Efficient transcriptional targeting of human hematopoietic stem cells and blood cell lineages by lentiviral vectors containing the regulatory element of the Wiskott-Aldrich syndrome geneValeria Leuci, Loretta Gammaitoni, Sonia Capellero, et al.
Expert Opinion on Biological Therapy|December 18, 2014
Adoptive immunotherapy against sarcomasGiulia Mesiano, Valeria Leuci, Lidia Giraudo, et al.
Cells|November 27, 2021
EphA2 Expression in Bone Sarcomas: Bioinformatic Analyses and Preclinical Characterization in Patient-Derived Models of Osteosarcoma, Ewing's Sarcoma and ChondrosarcomaGiorgia Giordano, Alessandra Merlini, Giulio Ferrero, et al.
Pageof 3